With drug overdose fatalities declining nationwide, Anoka County is attempting to sustain this momentum by launching a free continuing education series on FacesOfHopeAnoka.org. The program targets the intersection of pain management and opioid prescribing, aiming to reduce risks for both medical providers and their patients.
Investors are turning their attention to Lindblad Expeditions Holdings, Inc. as the company prepares to disclose its second-quarter financial results on the morning of August 3, 2026. The announcement will precede the market opening, followed immediately by an audio conference call to review the company’s performance.
Biohaven is set to unveil updated clinical data for its FGFR3-directed antibody-drug conjugate, BHV-1530, at the upcoming ESMO Congress in Madrid. The company also secured a clinical supply agreement with Regeneron Pharmaceuticals to test the drug in combination with cemiplimab for patients with advanced solid tumors.
After a decade driving digital transformation at Changi Airport Group, Ng Yansheng has been tapped as the new Managing Director of YY Circle (SG) Pte. Ltd. The appointment aims to accelerate the growth of YY Group’s flexible manpower platform as demand for agile workforce solutions rises across Singapore’s service sectors.
San Jose-based engineering firm ACL Digital is joining forces with the AI-native platform Swantide to shrink Salesforce implementation timelines from months to days. The collaboration targets enterprises struggling to transition their legacy ecosystems into governance-ready foundations capable of supporting complex agentic AI deployments.
South American sustainable producer Adecoagro has signed a definitive agreement to purchase the Caarapó sugar and ethanol mill from the Raízen Group. The R$760 million cash deal, expected to close by October 1, 2026, marks a significant expansion of the company’s industrial cluster in the Brazilian state of Mato Grosso do Sul.
More than 15,000 founders, investors, and researchers are converging on Chicago this week for the fifth annual TechChicago Week. The event, organized by the nonprofit P33, aims to move beyond networking by tasking attendees with addressing systemic global issues through 13 anchor events and over 130 partner programs.
Global womenswear label Reformation has officially launched its roadshow for an initial public offering, targeting a valuation based on a share price between $15.00 and $17.00. The Los Angeles-based company plans to list its common stock on the New York Stock Exchange under the ticker symbol REF.
Greenbelt Capital Partners has secured a majority investment in Bowe & Gant Electrical Services, a New Jersey-based firm specializing in critical energy infrastructure. Founders Vincent Bowe and Gabriel Gant will retain significant equity stakes and continue to lead the company, which serves utility, data center, and renewable energy clients across the Northeast.
The global automotive powder coatings market is set to expand from $2.78 billion in 2026 to $3.59 billion by 2031, reflecting a compound annual growth rate of 5.22 percent. Increasing vehicle production and a shift toward sustainable, low-VOC coating solutions are driving this long-term industry valuation.
Investors holding Western Midstream Partners, LP units will receive a quarterly cash distribution of $0.93 per unit, matching the payout from the previous quarter. The board of directors confirmed the distribution, which represents an annualized rate of $3.72, is scheduled for payment on August 14, 2026.
When hundreds of women queued outside a bright pink shop in Oxford last Saturday, they weren't just hunting for books. The crowd gathered at Bad Girl Books—a specialty outlet for explicit romantasy—signaled a cultural pivot: a growing refusal to accept narrow, one-note definitions of female desire, whether in fiction or physiology.
Compugen Ltd. will report its financial results for the second quarter of 2026 before U.S. markets open on Monday, August 3. The Holon-based immunotherapy developer intends to use the morning session to provide investors with a comprehensive corporate update regarding its ongoing computational drug discovery programs.
Northridge-based diabetes technology specialist MiniMed will disclose its financial performance for the first quarter of fiscal year 2027 on September 1, 2026. The company intends to release its summary data shortly before the markets open, followed by a scheduled webcast to review the period ending July 31.
Overland Park-based Examinetics has finalized the acquisition of Progressive Safety and Jurgiel & Associates, marking the firm's fourth and fifth strategic deals in 18 months. The move bolsters the company’s industrial hygiene capabilities and adds rapid-deployment safety staffing to its national occupational health and compliance portfolio.
Azour-based mobility technology firm Ituran Location and Control Ltd. will release its second quarter 2026 financial results on Wednesday, August 12, 2026. Management plans to host a video conference call later that same day to review the figures and field questions from the investment community.
McKinney-based Globe Life Inc. will release its financial results for the second quarter of 2026 on Wednesday, July 22, following the close of market trading. The announcement marks the latest performance update for the holding company, which focuses on life and supplemental health insurance products for middle-income consumers.
Princeton-based medical technology firm CytoSorbents Corporation will host a conference call on August 6, 2026, to disclose its financial results for the second quarter. The company, which specializes in blood purification systems for intensive care and cardiac surgery, will also present recent business highlights following the market close.
BioLineRx and Hemispherian AS will present new preclinical findings at the ESMO 2026 Congress in Madrid this October, highlighting how their small molecule, GLIX1, enhances the efficacy of PARP inhibitors in HR-proficient ovarian cancer cells, a group that currently faces limited treatment options.
Mentari Therapeutics has appointed Greg Divis as its new Chief Executive Officer and board member, effective July 20, 2026. The biotechnology firm, which focuses on novel migraine prevention treatments, looks to leverage Divis’s track record in commercializing pharmaceutical products to guide its upcoming clinical development milestones.
Highway Holdings reported a shift to operating profitability for the first quarter of fiscal 2027, posting $59,000 in operating income. The Hong Kong-based manufacturer overcame the loss of a long-term Myanmar customer by driving a 29% revenue increase and expanding gross margins by 800 basis points to 42%.
With over 700 children killed in traffic accidents annually, Mag Instrument is partnering with the Pedestrian Safety Institute to deploy a new educational initiative. The program, Safe Road Adventures, aims to equip K-5 students with vital street-safety habits through an interactive curriculum designed to reduce preventable roadside fatalities.
Clinical-stage biotech Marengo Therapeutics will present Phase 2 data from its STARt-001 study at the 2026 ESMO Congress, showcasing the efficacy of invikafusp alfa in patients resistant to PD-1 therapies. To steer this next development phase, the company has appointed former Merck oncology leader Dr. Eric Rubin to its advisory board.
The television series Advancements with Ted Danson returns to Bloomberg TV on Saturday, July 25, at 8:00 PM ET, featuring an exploration of how emerging technologies are reshaping the cybersecurity, advertising, energy, and medical manufacturing sectors in an increasingly complex global landscape.
Investors will receive a comprehensive look at the fiscal health of Terex Corporation on July 30, 2026, as the company prepares to host a conference call detailing its second-quarter results. The session begins at 8:30 a.m. Eastern Time, led by CEO Simon Meester and CFO Jennifer Kong-Picarello.
Armata Pharmaceuticals has finalized its regulatory submissions to the U.S. Food and Drug Administration, clearing a path for a pivotal Phase 3 superiority study of its AP-SA02 bacteriophage candidate. The company expects to launch the trial in the second half of 2026 to treat complicated S. aureus bacteremia.
Medtronic plc will disclose its financial performance for the first quarter of fiscal year 2027 on Tuesday, September 1, 2026. The Ireland-based healthcare technology giant, which concludes its current quarter on July 31, plans to release summary data ahead of a scheduled investor webcast later that morning.
Nordiq Canada has finalized a four-year contract extension with USANA Health Sciences, ensuring the nutritional firm remains the primary supplier for the nation’s elite cross-country ski team. The agreement guarantees that athletes will continue to receive NSF Certified for Sport products through the 2030 Olympic Winter Games.
As baby boomer business owners across Canada confront a looming succession crisis, Las Vegas-based firm Reins is expanding its operations north of the border. The company aims to help independent firms stabilize their workforce by offering phantom stock and profit-sharing models without requiring owners to relinquish actual company control.
PowerBank Corporation has secured a lease for its 3.2 MW Scofield solar project in Broome County, New York, marking a strategic pivot from its previously announced Boyle Rd. development. The company anticipates the installation will qualify for federal Investment Tax Credits under the 2025 One Big Beautiful Bill Act.
